Komori
KYORIN Pharmaceutical (4569) · PolicyRestated

Addressing Unmet Medical Needs and Continuously Creating Innovative New Drugs

First written in FY2017-Q1. 20 of 21 entries say "Restated". Latest entry: FY2024-Q3.

21entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017-Q1 – FY2024-Q32016: 220162017: 320172018: 320182019: 320192020: 320202021: 320212022: 220222023: 120232024: 1
Same theme, other companies

2 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2024-Q3RestatedAnnual report

    「Our group believes that its mission is to continue providing high-value new drugs that meet medical needs and contribute to people's health.」

    It reconfirms its mission of continuously providing high-value new drugs that meet medical needs.
  2. FY2024-Q2RestatedAnnual report

    「Our group believes that its mission is to continue providing high-value new drugs that meet medical needs and contribute to people's health.」

    It reconfirms its mission of continuously providing high-value new drugs that meet medical needs.
  3. FY2023-Q1RestatedAnnual report

    「We believe that it is the mission of a new drug manufacturer to continue creating and disseminating new drugs that meet the many unmet medical needs that still exist and contribute to the health of people around the world.」

    It continues to pursue addressing unmet medical needs and continuously creating and disseminating new drugs as the mission of a new drug manufacturer.
  4. FY2022-Q3RestatedAnnual report

    「We believe that it is the mission of a new drug manufacturer to continue creating and disseminating new drugs that meet the many unmet medical needs that still exist and contribute to the health of people around the world.」

    It continues to pursue addressing unmet medical needs and continuously creating and disseminating new drugs as the mission of a new drug manufacturer.
  5. FY2022-Q2RestatedAnnual report

    「We believe that it is the mission of a new drug manufacturer to continue creating and disseminating new drugs that meet the many unmet medical needs that still exist and contribute to the health of people around the world.」

    It continues to pursue addressing unmet medical needs and continuously creating and disseminating new drugs as the mission of a new drug manufacturer.
  6. FY2022-Q1RestatedAnnual report

    「We believe that it is the mission of a new drug manufacturer to continue creating and delivering new drugs that meet the many unmet medical needs that still exist and contribute to the health of people around the world.」

    It continues to pursue addressing unmet medical needs and continuously creating and providing new drugs as its mission.
  7. FY2021-Q3RestatedAnnual report

    「For a new drug manufacturer, we believe that the mission is to continue creating and delivering new drugs that meet the many unmet medical needs that still exist and contribute to the health of people around the world.」

    It reconfirms addressing unmet medical needs and continuously creating and providing new drugs as its mission.
  8. FY2021-Q2RestatedAnnual report

    「For a new drug manufacturer, we believe that the mission is to continue creating and delivering new drugs that meet the many unmet medical needs that still exist and contribute to the health of people around the world.」

    It reconfirms addressing unmet medical needs and continuously creating and providing new drugs as its mission.
  9. FY2021-Q1RestatedAnnual report

    「For a new drug manufacturer, the mission is to continue creating and delivering new drugs that meet the many unmet medical needs that still exist and contribute to the health of people around the world.」

    It reconfirms addressing unmet medical needs and continuously creating and providing new drugs as the mission of a new drug manufacturer.
  10. FY2020-Q3RestatedAnnual report

    「For a new drug manufacturer, the mission is to continue creating and delivering innovative new drugs that meet the many unmet medical needs that still exist and contribute to the health of people around the world.」

    It reconfirms addressing unmet medical needs and continuously creating and providing innovative new drugs as its mission.
  11. FY2020-Q1RestatedAnnual report

    「For a new drug manufacturer, the mission is to continue creating and delivering innovative new drugs that meet the many unmet medical needs that still exist and contribute to the health of people around the world.」

    It reconfirms addressing unmet medical needs and continuously creating and providing innovative new drugs as its mission.
  12. FY2019RestatedAnnual report

    「For a new drug manufacturer, the mission is to continue creating innovative new drugs that meet the many unmet medical needs that still exist and contribute to the health of people around the world.」

    It reconfirms addressing unmet medical needs and continuously creating innovative new drugs as its mission.
  13. FY2019-Q3RestatedAnnual report

    「For a new drug manufacturer, the mission is to continue creating and delivering innovative new drugs that meet the many unmet medical needs that still exist and contribute to the health of people around the world.」

    It reconfirms addressing unmet medical needs and continuously creating and providing innovative new drugs as its mission.
  14. FY2019-Q2RestatedAnnual report

    「For a new drug manufacturer, the mission is to continue creating and delivering innovative new drugs that meet the many unmet medical needs that still exist and contribute to the health of people around the world.」

    It reconfirms addressing unmet medical needs and continuously creating and providing innovative new drugs as its mission.
  15. FY2018RestatedAnnual report

    「For a new drug manufacturer, the mission is to continue creating and delivering innovative new drugs that meet the many unmet medical needs that still exist and contribute to the health of people around the world.」

    It reconfirms addressing unmet medical needs and continuously creating and providing innovative new drugs as its mission.
  16. FY2018-Q3RestatedAnnual report

    「For a new drug manufacturer, the mission is to continue creating and delivering innovative new drugs that meet the many unmet medical needs that still exist and contribute to the health of people around the world.」

    It reconfirms addressing unmet medical needs and continuously creating and providing innovative new drugs as its mission.
  17. FY2018-Q2RestatedAnnual report

    「For a new drug manufacturer, the mission is to continue creating and delivering innovative new drugs that meet the many unmet medical needs that still exist and contribute to the health of people around the world.」

    It reconfirms addressing unmet medical needs and continuously creating and providing innovative new drugs as its mission.
  18. FY2017RestatedAnnual report

    「For an innovative pharmaceutical company, our mission is to address the many unmet medical needs that remain and continuously create and deliver innovative new drugs that contribute to the health of people worldwide.」

    It reconfirms addressing unmet medical needs and continuously creating innovative new drugs as its mission.
  19. FY2017-Q3RestatedAnnual report

    「For an innovative pharmaceutical company, our mission is to address the many unmet medical needs that remain and continuously create and deliver innovative new drugs that contribute to the health of people worldwide.」

    It reconfirms addressing unmet medical needs and continuously creating innovative new drugs as its mission.
  20. FY2017-Q2RestatedAnnual report

    「For an innovative pharmaceutical company, our mission is to address the many unmet medical needs that remain and continuously create and deliver innovative new drugs that contribute to the health of people worldwide.」

    It reconfirms addressing unmet medical needs and continuously creating innovative new drugs as its mission.
  21. FY2017-Q1First statedAnnual report

    「For an innovative pharmaceutical company, our mission is to address the many unmet medical needs that remain and continuously create and deliver innovative new drugs that contribute to the health of people worldwide.」

    The mission of an innovative pharmaceutical company is described as addressing unmet medical needs and continuously creating and providing innovative new drugs.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for KYORIN Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Addressing Unmet Medical Needs and Continuously Creating Innovative New Drugs | KYORIN Pharmaceutical Co.,Ltd. (4569) | Komori